4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-23-020038
President & CEO sold 12,500 shares at $32.60 ($407,500)
- President & CEO acquired 12,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Blum Robert I President & CEO | 2023-07-03 | Option exercise 10b5-1 | +12,500 | $9.65 | $120,625 | 453,917 | D: show line 1 in the form |
| Blum Robert I President & CEO | 2023-07-03 | Sale 10b5-1 | −12,500 | $32.60 | $407,500 | 441,417 | D: show line 2 in the form |
| Open-market sales · 12,500 sh · avg $32.60 · $407,500 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Blum Robert I President & CEO | 2023-07-03 | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −12,500 | 33,191 | D: show line 3 in the form |
Loading xslF345X04/form4.xml…